Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease
Launched by ASSIUT UNIVERSITY · Mar 27, 2018
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
* Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat (\>5%) in liver cells in the absence of excessive alcohol intake or other causes of liver disease. The histologic spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), liver fibrosis, and cirrhosis. This disease affects up to 30% of the general population in Western countries, especially in patients with metabolic syndrome, obesity, and type II diabetes.
* Accumulating epidemiologic evidence indicates that NAFLD not only affects the liver but also increases the risk of extra-hepatic dise...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • •Patients diagnosed as NAFLD by abdominal ultrasonography, Fibroscan, NAFLD fibrosis score and FIB-4 score
- Exclusion Criteria:
- • Patients with diabetes and/or hypertension.
- • Patients with chronic renal disease.
- • Patients with urinary tract infections.
- • Patients on medications affecting the kidney (eg: NSAIDs,..etc)
- • Patients with chronic liver disease other than NAFLD (chronic hepatitis; viral B,C, autoimmune etc).
- • Alcohol consumption.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials